Methylprednisolone Sodium Succinate Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-255

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 63323-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Met15 0003 01)

Chemical structure of Methylprednisolone Sodium Succinate showing its molecular arrangement and labeled with a molecular weight of 496.53.*

FDA Label Image

Fresenius Kabi Logo (Met15 0003 02)

FDA Label Image

Vial (Met15 0003 03)

Label for Methylprednisolone Sodium Succinate for Injection, USP, with strength of 40 mg per vial. It is a single dose vial to be reconstituted with 1 mL Bacteriostatic Water for Injection with Benzyl Alcohol. The label includes usage instructions and the labeler information, Fresenius Kabi, Lake Zurich, IL.*

FDA Label Image

Tray (Met15 0003 04)

Label for Methylprednisolone Sodium Succinate for Injection, USP, 40 mg per 1 mL vial by APP Pharmaceuticals, LLC. The label indicates it is a single-dose vial for intravenous or intramuscular use, containing 1 mL per vial, with 25 vials per package. It includes reconstitution and storage instructions and a barcode.*

FDA Label Image

Vial1 (Met15 0003 05)

Label for Methylprednisolone Sodium Succinate for Injection, USP, 125 mg per vial. Instructions state to reconstitute with 2 mL Bacteriostatic Water for Injection with Benzyl Alcohol, use within 48 hours after mixing, and it is for intravenous or intramuscular use. The vial is single dose, Rx only. Labeler is Fresenius Kabi, Lake Zurich, IL.*

FDA Label Image

Tray1 (Met15 0003 06)

Methylprednisolone Sodium Succinate for Injection, USP, 125 mg per vial, 2 mL single dose vial. The label indicates use for intravenous or intramuscular injection, sterile with benzyl alcohol, packed as 25 vials. Manufactured by APP Pharmaceuticals, LLC, with storage and preparation instructions included.*

FDA Label Image

Vial2 (Met15 0003 07)

Label for Methylprednisolone Sodium Succinate for Injection, USP, 1 gram per vial, by APP Pharmaceuticals, LLC. It is for intravenous or intramuscular use, contains benzyl alcohol as a preservative, and is a multiple dose vial with 8-125 mg doses. The label includes instructions for reconstitution with 16 mL bacteriostatic water for injection with benzyl alcohol.*

FDA Label Image

Pbox (Met15 0003 08)

Label for Methylprednisolone Sodium Succinate for Injection, USP, 1 gram per vial. The label states the product is for intravenous or intramuscular use and includes instructions to reconstitute with 16 mL bacteriostatic water for injection containing benzyl alcohol as a preservative. The label notes this is a single multiple-dose vial and provides storage and handling information. It is labeled by APP Pharmaceuticals, LLC, trading as Fresenius Kabi in Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.